63
Growth Score
pts
Heat Score
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
416491
Paratope Bio focuses on immuno-oncology, developing less toxic cancer treatments using innate antibodies.
- Gregory F. Sullivan: Founder & CEO
About the Company
Paratope Bio specializes in the field of immuno-oncology, focusing on the development of cancer treatments with reduced toxicity. The company is dedicated to advancing drug development by creating a sophisticated set of innate antibodies designed to minimize adverse effects on patients. With a team of experts in biotechnology, Paratope Bio aims to
contribute significantly to the oncology sector by offering innovative solutions for cancer therapy. The company's approach involves leveraging scientific research to produce treatments that are both effective and safer for patients, addressing the critical need for less harmful cancer therapies in the healthcare industry.
